{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:48:08Z","timestamp":1764402488422,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["neuromodulationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromodulation: Technology at the Neural Interface"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1111\/j.1525-1403.2011.00334.x","type":"journal-article","created":{"date-parts":[[2011,3,3]],"date-time":"2011-03-03T03:57:20Z","timestamp":1299124640000},"page":"219-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Psychiatric Predisposition to Autonomic and Abnormal Perception Side-Effects of Ziconotide: A Case Series Study"],"prefix":"10.1016","volume":"14","author":[{"given":"Paolo","family":"Poli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Ciaramella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1525-1403.2011.00334.x_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3458.2000.tb00134.x","article-title":"Analgesic properties of ziconotide, a selective blocker of N-type neuronal calcium channels","volume":"6","author":"Wang","year":"2000","journal-title":"CNS Drug Rev"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3959(90)91074-S","article-title":"A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury","volume":"43","author":"Seltzer","year":"1990","journal-title":"Pain"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0304-3959(96)03271-X","article-title":"Blockade of spinal N- and P-type, but not L-type, calcium channels inhibits the excitability of rat dorsal horn neurons produced by subcutaneous formalin inflammation","volume":"69","author":"Diaz","year":"1997","journal-title":"Pain"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0304-3959(95)01441-1","article-title":"Characterization of a rat model of incisional pain","volume":"64","author":"Brennan","year":"1996","journal-title":"Pain"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00002508-199709000-00012","article-title":"Use of intrathecal ziconotide, a novel, N-type, voltage-sensitive, calcium channel blocker, in the management of intractable brachial plexus avulsion pain","volume":"13","author":"Brose","year":"1997","journal-title":"Clin J Pain"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib6","first-page":"697","article-title":"Chronic, opioid-resistant, neuropathic pain: marked analgesic efficacy of intrathecal ziconotide","volume":"17","author":"Presley","year":"1998","journal-title":"Am Pain Soc Abstr"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0006-8993(94)90637-8","article-title":"Effects of diverse omega-conopeptides on the in vivo release of glutamic and gamma-aminobutyric acids","volume":"638","author":"Newcomb","year":"1994","journal-title":"Brain Res"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0896-6273(00)81246-5","article-title":"Either N- or P-type calcium channels mediate GABA release at distinct hippocampal inhibitory synapses","volume":"18","author":"Poncer","year":"1997","journal-title":"Neuron"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0304-3940(92)90039-A","article-title":"Release of calcitonin gene-related peptide like-immunoreactivity induced by electrical field stimulation from rat spinal afferents is mediated by conotoxin-sensitive calcium channels","volume":"136","author":"Santicioli","year":"1992","journal-title":"Neurosci Lett"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0306-4522(95)00353-3","article-title":"Mechanism of prostaglandin E2-induced substance P release from cultured sensory neurons","volume":"70","author":"White","year":"1996","journal-title":"Neuroscience"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/PL00005150","article-title":"Peripheral versus central potencies of N-type voltage sensitive calcium channel blockers","volume":"357","author":"Wang","year":"1998","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib12","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1523\/JNEUROSCI.18-16-06319.1998","article-title":"Localization of Ca2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals","volume":"18","author":"Westenbroek","year":"1998","journal-title":"J Neurosci"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1146\/annurev.physiol.60.1.327","article-title":"Electrical and calcium signaling in dendrites of hippocampal pyramidal neurons","volume":"60","author":"Magee","year":"1998","journal-title":"Annu Rev Physiol"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0006-8993(94)90398-0","article-title":"Neuroanatomical distribution of receptors for a novel voltage-sensitive calcium-channel antagonist, SNX-230 (omega-conopeptide MVIIC)","volume":"653","author":"Gohil","year":"1994","journal-title":"Brain Res"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0014-2999(88)90501-8","article-title":"Autoradiographic localization of calcium channels with [125I]omega-conotoxin in rat brain","volume":"146","author":"Kerr","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib16","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/brain\/103.4.717","article-title":"The substantia gelatinosa of the spinal cord: a critical review","volume":"103","author":"Cervero","year":"1980","journal-title":"Brain"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0304-3959(99)00254-7","article-title":"Ziconotide effects associated with the intrathecal administration of ziconotide","volume":"85","author":"Penn","year":"2000","journal-title":"Pain"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2147\/TCRM.S4438","article-title":"Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain","volume":"5","author":"Smith","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1525-1403.2006.00055.x","article-title":"Intrathecal ziconotide in the treatment of chronic nonmalignant pain: a randomized, double-blind, placebo-controlled clinical trial","volume":"9","author":"Wallace","year":"2006","journal-title":"Neuromodulation"},{"issue":"4","key":"10.1111\/j.1525-1403.2011.00334.x_bib20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1525-1403.2007.00128.x","article-title":"Polyanalgesic Consensus Conference 2007: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel","volume":"10","author":"Deer","year":"2007","journal-title":"Neuromodulation"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jpainsymman.2005.10.003","article-title":"Ziconotide 301 Study Group. A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain","volume":"31","author":"Rauck","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib22","first-page":"147","article-title":"Treatment challenges and complications with zyconotide monotherapy in established pump patients","volume":"9","author":"Thompson","year":"2006","journal-title":"Pain Physician"},{"year":"1994","series-title":"Classification of chronic pain: description of chronic pain syndromes and definition of pain terms","author":"Merskey","key":"10.1111\/j.1525-1403.2011.00334.x_bib23"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3959(88)90203-5","article-title":"The Italian pain questionnaire","volume":"33","author":"De Benedittis","year":"1988","journal-title":"Pain"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00000542-197101000-00017","article-title":"On the languages of pain","volume":"34","author":"Melzack","year":"1971","journal-title":"Anaesthesiology"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib27","series-title":"Handbook of pain assessment","first-page":"15","article-title":"Self\u2013report scales and procedures for assessing pain in adult","author":"Jensen","year":"1992"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib28","series-title":"Handbook of pain assessment","first-page":"35","article-title":"The McGill Pain Questionnaire: appraisal and current status","author":"Melzack","year":"1992"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib29","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1090-3801(03)00062-4","article-title":"When pain is not fully explained by organic lesion: a psychiatric perspective on chronic pain patients","volume":"8","author":"Ciaramella","year":"2004","journal-title":"Eur J Pain"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib31","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/BRS.0b013e31811329ac","article-title":"Psychiatric comorbidity in chronic disabling occupational spinal disorders has minimal impact on functional restoration socioeconomic outcomes","volume":"32","author":"Dersh","year":"2007","journal-title":"Spine"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib32","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.2009.723","article-title":"Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial","volume":"301","author":"Kroenke","year":"2009","journal-title":"JAMA"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib33","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/01.brs.0000216441.83135.6f","article-title":"Prevalence of psychiatric disorders in patients with chronic disabling occupational spinal disorders","volume":"31","author":"Dersh","year":"2006","journal-title":"Spine"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib34","series-title":"Neuropsychopharmacology. The fifth generation of progress","first-page":"902","article-title":"Neurobiological basis of anxiety disorders","author":"Charney","year":"2002"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1176\/appi.ajp.157.4.493","article-title":"Neuroanatomical hypothesis of panic disorder, revised","volume":"157","author":"Gorman","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0006-8993(89)91496-0","article-title":"Alterations of muscarinic cholinergic receptors in the hippocampal formation of stressed rat: in vitro quantitative autoradiographic analysis","volume":"478","author":"Mizukawa","year":"1989","journal-title":"Brain Res"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.mp.4000997","article-title":"Beyond the usual suspects: a cholinergic route for panic attacks","volume":"7","author":"Battaglia","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib38","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1523\/JNEUROSCI.20-17-06431.2000","article-title":"Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse","volume":"20","author":"Ross","year":"2000","journal-title":"J Neurosci"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neulet.2009.08.036","article-title":"Rostral ventral medulla cholinergic mechanism in pain-induced analgesia","volume":"464","author":"Gear","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib40","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1124\/jpet.104.079939","article-title":"M2, M3, and M4 receptor subtypes contribute to muscarinic potentiation of GABAergic inputs to spinal dorsal horn neurons","volume":"313","author":"Zhang","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib41","first-page":"105","article-title":"Involvement of central cholinergic system in antinociception induced by sumatriptan in mouse","volume":"17","author":"Ghelardini","year":"1997","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.302.1.397","article-title":"Presynaptic muscarinic M(2)-receptor-mediated inhibition of N-type Ca(2+) channels in cultured sphenopalatine ganglion: direct evidence for acetylcholine inhibition of cerebral nitrergic neurogenic vasodilation","volume":"302","author":"Liu","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib43","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0893-133X(99)00146-3","article-title":"Nicotine receptors in the brain: links between molecular biology and behavior","volume":"22","author":"Picciotto","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1471-4159.1996.67010163.x","article-title":"Voltage-sensitive Ca2+ channels involved in nicotinic receptor-mediated [3H]-dopamine release from rat striatal synaptosomes","volume":"67","author":"Soliakov","year":"1996","journal-title":"J Neurochem"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib45","doi-asserted-by":"crossref","first-page":"11712","DOI":"10.1523\/JNEUROSCI.3621-08.2008","article-title":"A blocker of N- and T-type voltage-gated calcium channels attenuates ethanol-induced intoxication, place preference, self-administration, and reinstatement","volume":"28","author":"Newton","year":"2008","journal-title":"J Neurosci"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4161\/chan.3.2.8037","article-title":"The N-type calcium channel is a novel target for treating alcohol use disorders","volume":"3","author":"Newton","year":"2009","journal-title":"Channels (Austin)"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib47","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pain.2007.01.022","article-title":"Mental disorders among persons with chronic back or neck pain: results from the World Mental Health Surveys","volume":"129","author":"Demyttenaere","year":"2007","journal-title":"Pain"},{"key":"10.1111\/j.1525-1403.2011.00334.x_bib48","first-page":"773","article-title":"Chronic pain and psychopathology: research findings and theoretical considerations","volume":"64","author":"Dersh","year":"2002","journal-title":"Psychosom Med"}],"container-title":["Neuromodulation: Technology at the Neural Interface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1525-1403.2011.00334.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715911600469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715911600469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1525-1403.2011.00334.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:47:35Z","timestamp":1761083255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094715911600469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1094715911600469"],"URL":"https:\/\/doi.org\/10.1111\/j.1525-1403.2011.00334.x","relation":{},"ISSN":["1094-7159"],"issn-type":[{"type":"print","value":"1094-7159"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychiatric Predisposition to Autonomic and Abnormal Perception Side-Effects of Ziconotide: A Case Series Study","name":"articletitle","label":"Article Title"},{"value":"Neuromodulation: Technology at the Neural Interface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1525-1403.2011.00334.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 International Neuromodulation Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}